While sPLA2 has been previously reported as a biomarker of sepsis,25, 62 here we expand this observation mechanistically to link sPLA2 to the breadth of its discrete eicosanoid products, the immune cellular responses that they influence and the consequent indices of disease severity. The gene discussed is PLA2G2A; the disease is Sepsis.